Charlotte, North Carolina
CNS medication trials in Charlotte, NC
22 CNS medication studies are recruiting participants at sites in Charlotte as of November 17, 2026, according to ClinicalTrials.gov. CNS Medication Trials can help you understand your options and connect with a study team.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Charlotte at a glance
- 22 studies are recruiting at a site in Charlotte.
- By phase: Phase 1 (1), Phase 2 (4), Phase 3 (16), Phase 4 (1).
- By sponsor: industry (21), university, hospital or other (1).
- By research area: Migraine (6), Depression (5), Epilepsy (4), Multiple Sclerosis (3), Parkinson's Disease (3), Schizophrenia (1).
- Most recent update to one of these records: November 17, 2026.
Depression studies recruiting in Charlotte
Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Study site
- New Hope Clinical Research
- Registry record
- NCT07226661 · updated
ALTO-207 in Adults With Treatment-resistant Depression (TRD)
- Phase 2
- Ages 18 to 75
- All sexes
- Sponsor
- Alto Neuroscience
- Registry record
- NCT07553637 · updated
A Study to Evaluate the Maintenance Effect of Osavampator as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT07196501 · updated
Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Vanda Pharmaceuticals
- Study site
- Vanda Investigational Site
- Registry record
- NCT06830044 · updated
NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Neurocrine Biosciences
- Study site
- Neurocrine Clinical Site
- Registry record
- NCT06963021 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Charlotte, NC on ClinicalTrials.gov.
Schizophrenia studies recruiting in Charlotte
A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Phase 2
- Ages 55 and older
- All sexes
- Sponsor
- Intra-Cellular Therapies, Inc.
- Study site
- New Hope Clinical Research
- Registry record
- NCT06540833 · updated
Source: ClinicalTrials.gov. Data processed . See every schizophrenia study recruiting in Charlotte, NC on ClinicalTrials.gov.
Parkinson's disease studies recruiting in Charlotte
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Novant Health Weisiger Cancer Insititute ( Site 0266)
- Registry record
- NCT06623422 · updated
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- AstraZeneca
- Registry record
- NCT06989112 · updated
A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Study site
- Levine Cancer Institute ( Site 0014)
- Registry record
- NCT06312176 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Charlotte, NC on ClinicalTrials.gov.
Multiple sclerosis (MS) studies recruiting in Charlotte
Study to Evaluate Safety, Efficacy and Pharmacokinetics (PK) of a Modified Regimen of Ublituximab
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- TG Therapeutics, Inc.
- Study site
- TG Therapeutics Investigational Trial SiteCharlotte
- Registry record
- NCT05877963 · updated
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 65
- All sexes
- Sponsor
- Novartis Pharmaceuticals
- Study site
- Atrium Health
- Registry record
- NCT07225504 · updated
Non-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Sanofi
- Study site
- Piedmont HealthCare - Lake Norman Neurology- Site Number : 8400002
- Registry record
- NCT07325292 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Charlotte, NC on ClinicalTrials.gov.
Epilepsy studies recruiting in Charlotte
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
- Phase 3
- Ages 12 and older
- All sexes
- Sponsor
- Xenon Pharmaceuticals Inc.
- Study sites
- Atrium Health · Onsite Clinical Solutions, LLC
- Registry record
- NCT05667142 · updated
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
- Phase 3
- Ages 2 to 55
- All sexes
- Sponsor
- Epygenix
- Study sites
- Atrium Health STRIVE Research · On-Site Clinical Solution
- Registry record
- NCT05066217 · updated
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Study site
- OnSite Clinical Solutions, LLC
- Registry record
- NCT06798896 · updated
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
- Phase 1
- Ages 18 to 70
- All sexes
- Sponsor
- Suninflam Inc
- Study site
- OnSite Clinical Solutions, LLC
- Registry record
- NCT07051629 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Charlotte, NC on ClinicalTrials.gov.
Migraine studies recruiting in Charlotte
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Phase 4
- Ages 18 to 70
- All sexes
- Sponsor
- Mayo Clinic
- Study sites
- Onsite Clinical Solutions Ballantyne · Onsite Clinical Solutions Mecklenburg · Onsite Clinical Solutions Park Cedar Dr.
- Registry record
- NCT06972056 · updated
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- OnSite Clinical Solutions
- Registry record
- NCT07645924 · updated
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Study site
- OnSite Clinical Solutions
- Registry record
- NCT07674654 · updated
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- OnSite Clinical Solutions, LLC
- Registry record
- NCT04649242 · updated
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- Pfizer
- Study site
- OnSite Clinical Solutions, LLC
- Registry record
- NCT04743141 · updated
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- Phase 3
- Ages 6 to 17
- All sexes
- Sponsor
- AbbVie
- Study site
- Onsite Clinical Solutions - Don Lochman Lane - Charlotte /ID# 282834
- Registry record
- NCT05125302 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Charlotte, NC on ClinicalTrials.gov.
Ask about studies near Charlotte
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.
CNS Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections